Clearmind Medicine Completes Second Patient Cohort for AUD Trial
Vancouver-based Clearmind Medicine Inc. has successfully completed the enrollment of six patients for the second cohort in its ongoing FDA-approved Phase I/IIa clinical trial of CMND-100, its proprietary drug candidate…